S230: CD22 CAR T CELL THERAPY IS SAFE AND EFFECTIVE IN PATIENTS WITH LARGE B CELL LYMPHOMA WHO HAVE RELAPSED AFTER CD19 CAR T CELL THERAPY.

ABSTRACT:

SUBMITTER: Frank M 

PROVIDER: S-EPMC10428455 | biostudies-literature | 2023 Aug

REPOSITORIES: biostudies-literature